JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Moore, P. E.
Right arrow Articles by Green, H. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Moore, P. E.
Right arrow Articles by Green, H. D.
Journal of Pharmacology And Experimental Therapeutics, Vol. 106, Issue 1, 14-23, 1952
Copyright © 1952 by American Society for Pharmacology and Experimental Therapeutics


EFFECTS OF A NEW DIBENZAZEPINE DERIVATIVE, RO 2-3248, 6-ALLYL-6,7-DIHYDRO-5H-DIBENZ[c,e]AZEPINE PHOSPHATE, UPON THE BLOOD FLOW, THE PERIPHERAL RESISTANCE AND THE RESPONSE TO INJECTIONS OF EPINEPHRINE OF THE INNERVATED HIND LIMB OF THE DOG

Paul E. Moore 1, Alfred W. Richardson 1, and Harold D. Green 1

1 Department of Physiology and Pharmacology, Bowman Gray School of Medicine of Wake Forest College, Winston-Salem, N. C.

1. The responses to a new dibenzazepine, adrenergic blocking drug, Ro 2-3248, and to epinephrine before and after the Ro 2-3248 were studied by recording their effects on the blood flow in the femoral artery of a normally innervated dog's leg; measurments were made with an electronically operated, differential pressure, direct writing, flowmeter.

2. When injected intra-arterially in doses of 0.3 to 10 mgm., Ro 2-3248 proved to be a prompt, moderately long-lasting vasodilator. Tachyphylaxis was not seen with repeated intra-arterial injections of 0.5 mgm. of Ro 2-3248.

3. One microgm. of epinephrine intra-arterially always induced pure vasoconstriction. After an average dose of 0.97 mgm./kgm. (8.9 mgm.) of Ro 2-3248 intra-arterially, the response to 1 microgm. of epinephrine injected intra-arterially was pure vasodilation. This reversal of response persisted in the different experiments for from 1 hour and 17 minutes to 5 hours and 36 minutes. The normal vasoconstrictor response to epinephrine was blocked for a considerably longer period.

4. One mgm./kgm. of Ro 2-3248 intravenously produced a prolonged fall in arterial blood pressure and reversed the flow response to intravenous injections of 1 microgm./kgm. of epinephrine for approximately three-quarters of an hour.

5. Ro 2-3248 in a dose sufficient to reverse the response to 1 microgm. of epinephrine, reversed the blood flow response to all doses up to 60 microgm. of epinephrine injected intra-arterially.

6. Increasing the dose of Ro 2-3248 to 2 to 4 mgm./kgm. did not cause the vasodilator response to 1 microgm. of epinephrine to be any greater than that seen with the 1 mgm./kgm. dose just necessary to reverse fully the flow response to this dose of epinephrine.

7. Milligram for milligram Ro 2-3248 intra-arterially was as effective as Priscoline, and about one-sixth as effective as Regitine in reversing the response to intra-arterial injections of 1 microgm. of epinephrine, but the reversal lasted longer than that of either of the latter two drugs.

8. Doses of Ro 2-3248 up to 16 mgm./kgin. given as an intravenous infusion to anesthetized dogs over a half hour period caused no fatalities.

Submitted on March 12, 1952




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
J. M. Stallworth, W. H. Lee JR, and J. Vernon Jeffords
Methods Used to Evaluate Vasodilator Drugs
Angiology, January 1, 1958; 9(6): 366 - 377.
[PDF]


Home page
ANGIOLOGYHome page
J. Vernon Jeffords and J. Manly Stallworth
The Effects of Azapetine Infusions on Patients With Vascular Disease: Preliminary Report
Angiology, October 1, 1956; 7(5): 445 - 453.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1952 by the American Society for Pharmacology and Experimental Therapeutics.